Search Results

There are 980 results for: content related to: Mechanisms of synergism between antagonists of growth hormone-releasing hormone and antagonists of luteinizing hormone-releasing hormone in shrinking experimental benign prostatic hyperplasia

  1. You have free access to this content
    Mechanisms of inhibition of human benign prostatic hyperplasia in vitro by the luteinizing hormone-releasing hormone antagonist cetrorelix

    BJU International

    Volume 106, Issue 9, November 2010, Pages: 1382–1388, Agnieszka Siejka, Andrew V. Schally, Norman L. Block and Nektarios Barabutis

    Version of Record online : 11 FEB 2010, DOI: 10.1111/j.1464-410X.2010.09215.x

  2. You have free access to this content
    A randomised controlled trial comparing GnRH antagonist Cetrorelix with GnRH agonist Leuprorelin for endometrial thinning prior to transcervical resection of endometrium

    BJOG: An International Journal of Obstetrics & Gynaecology

    Volume 115, Issue 10, September 2008, Pages: 1214–1224, K Bhatia, Y Doonan, A Giannakou and B Bentick

    Version of Record online : 11 AUG 2008, DOI: 10.1111/j.1471-0528.2008.01837.x

    Corrected by:


    Vol. 115, Issue 13, 1723, Version of Record online: 13 NOV 2008

  3. Gonadotrophin-releasing hormone antagonists for assisted reproductive technology

    Intervention Review

    The Cochrane Library

    Hesham G Al-Inany, Mohamed A Youssef, Reuben Olugbenga Ayeleke, Julie Brown, Wai Sun Lam and Frank J Broekmans

    Published Online : 29 APR 2016, DOI: 10.1002/14651858.CD001750.pub4

  4. LHRH antagonist Cetrorelix reduces prostate size and gene expression of proinflammatory cytokines and growth factors in a rat model of benign prostatic hyperplasia

    The Prostate

    Volume 71, Issue 7, 15 May 2011, Pages: 736–747, Ferenc G. Rick, Andrew V. Schally, Norman L. Block, Gabor Halmos, Roberto Perez, Jesus B. Fernandez, Irving Vidaurre and Luca Szalontay

    Version of Record online : 13 OCT 2010, DOI: 10.1002/pros.21289

  5. The combination of antagonists of LHRH with antagonists of GHRH improves inhibition of androgen sensitive MDA-PCa-2b and LuCaP-35 prostate cancers

    The Prostate

    Volume 67, Issue 12, 1 September 2007, Pages: 1339–1353, Anton Stangelberger, Andrew V. Schally, Marta Zarandi, Elmar Heinrich, Kate Groot, Alexandre Havt, Celia A. Kanashiro, Jozsef L. Varga and Gabor Halmos

    Version of Record online : 11 JUL 2007, DOI: 10.1002/pros.20605

  6. Sustained suppression of serum LH, FSH and testosterone and increase of high-density lipoprotein cholesterol by daily injections of the GnRH antagonist cetrorelix over 8 days in normal men

    Clinical Endocrinology

    Volume 40, Issue 2, February 1994, Pages: 241–248, Hermann M. Behre, Anja Böckers, Annette Schlingheider and Eberhard Nieschlag

    Version of Record online : 17 MAR 2008, DOI: 10.1111/j.1365-2265.1994.tb02475.x

  7. Comparison of the antigonadotropic activity of three GnRH antagonists (Nal-Glu, Antide and Cetrorelix) in a non-human primate model (Macaca fascicularis)


    Volume 25, Issue 3, May-June 1993, Pages: 141–147, G. F. Weinbauer and Professor Dr. E. Nieschlag

    Version of Record online : 24 APR 2009, DOI: 10.1111/j.1439-0272.1993.tb02698.x

  8. Synthesis of [U-14C]Arg labelled decapeptide cetrorelix, a novel lutenizing hormone — releasing hormone antagonist

    Journal of Labelled Compounds and Radiopharmaceuticals

    Volume 34, Issue 11, November 1994, Pages: 1091–1098, Mathias Locher, James Johnston, Thomas Müller, Harald O. Borbe, Bernhard Kutscher and Jürgen Engel

    Version of Record online : 26 JUL 2006, DOI: 10.1002/jlcr.2580341113

  9. Inhibitory effects of antagonists of growth hormone releasing hormone on experimental prostate cancers are associated with upregulation of wild-type p53 and decrease in p21 and mutant p53 proteins

    The Prostate

    Volume 72, Issue 5, April 2012, Pages: 555–565, Anton Stangelberger, Andrew V. Schally, Ferenc G. Rick, Jozsef L. Varga, Benjamin Baker, Marta Zarandi and Gabor Halmos

    Version of Record online : 27 JUL 2011, DOI: 10.1002/pros.21458

  10. Comparison of the effects of cetrorelix, a GnRH antagonist, and leuprolide, a GnRH agonist, on experimental endometriosis

    Journal of Obstetrics and Gynaecology Research

    Volume 34, Issue 6, December 2008, Pages: 1014–1019, Devrim Altintas, Arif Kokcu, Migraci Tosun, Mehmet B. Cetinkaya and Bedri Kandemir

    Version of Record online : 24 JUL 2008, DOI: 10.1111/j.1447-0756.2008.00807.x

  11. Novel Formulations of Cetrorelix Acetate in Healthy Men: Pharmacodynamic Effects and Noncompartmental Pharmacokinetics

    The Journal of Clinical Pharmacology

    Volume 42, Issue 9, September 2002, Pages: 995–1001, Dr. Katharina Erb, Dr. Klaus Junge, Dr. Birgit Pechstein, Dr. Edith Schneider, Dr. Hartmut Derendorf and Dr Robert Hermann

    Version of Record online : 19 MAR 2013, DOI: 10.1177/009127000204200906

  12. Luteinizing hormone-releasing hormone antagonist Cetrorelix (SB-75) and bombesin antagonist RC-3940-II inhibit the growth of androgen-independent PC-3 prostate cancer in nude mice

    The Prostate

    Volume 32, Issue 3, 1 August 1997, Pages: 164–172, Andreas Jungwirth, Georg Galvan, Jacek Pinski, Gabor Halmos, Karoly Szepeshazi, Ren-Zhi Cai, Kate Groot and Andrew V. Schally

    Version of Record online : 7 DEC 1998, DOI: 10.1002/(SICI)1097-0045(19970801)32:3<164::AID-PROS2>3.0.CO;2-L

  13. Neurotrophic effect of gonadotropin-releasing hormone on neurite extension and neuronal migration of embryonic gonadotropin-releasing hormone neurons in chick olfactory nerve bundle culture

    Journal of Neuroscience Research

    Volume 87, Issue 10, 1 August 2009, Pages: 2237–2244, Yoh-Ichiro Kanaho, Masahiro Enomoto, Daisuke Endo, Sayaka Maehiro, Min Kyun Park and Shizuko Murakami

    Version of Record online : 19 MAR 2009, DOI: 10.1002/jnr.22051

  14. You have free access to this content
    GnRH Agonists and Antagonists Stimulate Recovery of Fertility in Irradiated LBNF1 Rats

    Journal of Andrology


    Version of Record online : 2 JAN 2013, DOI: 10.1002/j.1939-4640.2001.tb02585.x

  15. You have free access to this content
    Kisspeptin-54 at high doses acutely induces testicular degeneration in adult male rats via central mechanisms

    British Journal of Pharmacology

    Volume 156, Issue 4, February 2009, Pages: 609–625, EL Thompson, V Amber, GWH Stamp, M Patterson, AE Curtis, JH Cooke, GF Appleby, WS Dhillo, MA Ghatei, SR Bloom and KG Murphy

    Version of Record online : 17 FEB 2009, DOI: 10.1111/j.1476-5381.2008.00061.x

  16. You have free access to this content
    Inhibition of the growth of caki-I human renal adenocarcinoma in Vivo by luteinizing hormone-releasing hormone antagonist cetrorelix, somatostatin analog RC-160, and bombesin antagonist RC-3940-II


    Volume 82, Issue 5, 1 March 1998, Pages: 909–917, Andreas Jungwirth, Andrew V. Schally, Gabor Halmos, Kate Groot, Karoly Szepeshazi, Jacek Pinski and Patricia Armatis

    Version of Record online : 31 OCT 2000, DOI: 10.1002/(SICI)1097-0142(19980301)82:5<909::AID-CNCR16>3.0.CO;2-4

  17. You have free access to this content
    Selection and Characterization of Mammalian Cell Lines with Stable Over-Expression of Human Pituitary Receptors for Gonadoliberin

    European Journal of Biochemistry

    Volume 231, Issue 3, August 1995, Pages: 535–543, Thomas Beckers, Kathrin Marheineke, Helmut Reiländer and Peter Hilgard

    Version of Record online : 3 MAR 2005, DOI: 10.1111/j.1432-1033.1995.0535d.x

  18. You have free access to this content
    Gonadotropin-Releasing Hormone Antagonist (Cetrorelix) Therapy Fails to Protect Nonhuman Primates (Macaca arctoides) From Radiation-Induced Spermatogenic Failure

    Journal of Andrology

    Volume 26, Issue 2, March-April 2005, Pages: 222–234, Kim Boekelheide, Heidi A. Schoenfeld, Susan J. Hall, Connie C. Weng, Gunapala Shetty, John Leith, James Harper, Mark Sigman, David L. Hess and Marvin L. Meistrich

    Version of Record online : 2 JAN 2013, DOI: 10.1002/j.1939-4640.2005.tb01089.x

  19. Pharmacokinetic/Pharmacodynamic Modeling of Luteinizing Hormone (LH) Suppression and LH Surge Delay by Cetrorelix after Single and Multiple Doses in Healthy Premenopausal Women

    The Journal of Clinical Pharmacology

    Volume 43, Issue 3, March 2003, Pages: 243–251, Dr. Nelamangala V. Nagaraja, Dr. Birgit Pechstein, Dr. Katharina Erb, Dr. Christine Klipping, Dr. Robert Hermann, Dr. Mathias Locher and Dr. Hartmut Derendorf

    Version of Record online : 8 MAR 2013, DOI: 10.1177/0091270003251377

  20. Effect of GnRH analogs on the expression of TrkA and p75 neurotrophin receptors in primary cell cultures from human prostate adenocarcinoma

    The Prostate

    Volume 65, Issue 3, 1 November 2005, Pages: 195–202, Catherine Sánchez, Marisa Clementi, Dixan Benitez, Héctor Contreras, Christian Huidobro and Enrique Castellón

    Version of Record online : 9 JUN 2005, DOI: 10.1002/pros.20281